MedTrace Logo

Effects of Topical Lidocaine During Urodynamic Testing In Women

NCT03881293 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2019-03-19

No results posted yet for this study

Summary

Urodynamic testing is used to help diagnose causes of urinary incontinence and voiding dysfunction. The purpose of the urodynamic test is to gain insight into the patient's urinary symptoms and assist in making a diagnosis. Catheter insertion and manipulation during the test can be uncomfortable for the patient. Lidocaine gel has not been used routinely during urodynamic testing. However, it is used routinely during outpatient cystoscopy and with any urethral catheterization. The investigators proposed that lidocaine numbing gel could be used without compromising test findings.

The study included 110 adult women. The purpose was:

1. Determine whether the use of topical lidocaine during urodynamic testing decreases patient discomfort during the procedure.
2. Evaluate whether the use of topical lidocaine affects the urodynamic results.

Conditions

  • Urinary Stress Incontinence
  • Pain

Interventions

DRUG

lidocaine 2% gel

Transurethral instillation of 5 ml lidocaine 2% gel

DRUG

water soluble lubricant

Transurethral instillation of 5 ml water soluble lubricant

Sponsors & Collaborators

  • Medical College of Wisconsin

    collaborator OTHER

  • WomenConnected

    collaborator UNKNOWN

  • Kristine Zinkgraf

    lead OTHER

Principal Investigators

  • Katherine Stevenson, MD · ProHealth Care

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2016-12-31
Completion
2016-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03881293 on ClinicalTrials.gov